FDA, Drug Ads

FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new guidelines, which have been over 15 years in the making, are designed to end industry practices that downplay or distract viewers from risk information.
New FDA rules for TV drug ads: Plain language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon, distracting visuals or audio effects. A 2007 law directed the FDA to ensure that drug risk information appears “in a clear, conspicuous and neutral manner.”
FDA implements new rules for drug ads
The U.S. Food and Drug Administration (FDA) has implemented new rules for TV drug ads to make them clearer and more direct in explaining medication risks and side effects.
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers from knowing risk information about drugs.
New FDA rules require TV drug ads to be more clear and direct
The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay or distract viewers from drug risks.
Why the FDA Wants TV Drug Ads to Use Simpler Words and Lose the Distractions
Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the Trump administration readies an offensive against big pharma.
New FDA Rules for TV Drug Ads: Simpler Language and No Distractions
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when explaining their medications' risks and side effects.
FDA puts new restrictions on TV ads for drugs
The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon.

RFK Jr.'s plan for changing U.S. food and drug system

US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
STAT13h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
FDA considers ban on cold remedy ingredient
The Food and Drug Administration (FDA) recently announced it is considering banning a common ingredient in popular ...
Analysis-RFK Jr vow to purge FDA sets up collision with Big Pharma
Robert F. Kennedy Jr. vowed to purge the U.S. Food and Drug Administration shortly before being chosen as President-elect Donald Trump's nominee for health secretary. Any changes he wants to make will ...
McDonald's Onion Recall Update as FDA Sets Highest Risk Level
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
federalnewsnetwork.com22h
FDA sees high vacancy rates for drug manufacturer inspectors
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
Monthly Prescribing Reference1h
FDA to Review Resubmitted Dupilumab sBLA for Chronic Spontaneous Urticaria
The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.
What to know about RFK Jr.'s stances on key health issues and what he could do at HHS
Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...
Agenus Top Brass Sued Over FDA Response to Cancer Drug Trial
Executives and directors of Agenus Inc. misled the public about the results of clinical trials for the biotech’s cancer ...